InsiderClue
← All stocks

Voyager Therapeutics, Inc.

VYGR Net buying
CIK 0001640266 #3912 in the set updated 17 Sep 2026
Bought (120 mo)
$91.90M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$24.96M
$316.75K on a plan · $1.64M straight out of an exercise
Sold at will
$23.00M
99 of 116 sales
Net
+$66.94M
+$68.90M against sales at will

By person

24 insiders · 123 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
NEUROCRINE BIOSCIENCES INC entity
10% owner
$89.03M (2)
—
+$89.03M
8,575,316
13.92%
$33.19M
—
Third Rock Ventures III, L.P. entity
10% owner
—
$12.72M (13)
−$12.72M
3,185,291
5.17%
$12.33M
−71.2%
EcoR1 Capital, LLC entity
10% owner
$2.66M (2)
$7.14M (3)
−$4.48M
3,851,507
6.25%
$14.91M
−9.9%
Henderson Jane
Sr. V.P. & CFO, Corp. Dev.
—
$1.03M (4) scheduled
−$1.03M
0
0.0000%
$0.00
—
Ravina Bernard
Chief Medical Officer
—
$848.62K (10)
−$848.62K
0
0.0000%
$0.00
−100.0%
Sandrock Alfred
President and CEO
—
$620.38K (10)
−$620.38K
472,549
0.7669%
$1.83M
+3,607%
Sah Dinah Ph.D.
Chief Scientific Officer
—
$468.69K (1) scheduled
−$468.69K
163,688
0.2656%
$633.47K
−3.7%
Swartz Robin
COO & CBO
—
$451.36K (18)
−$451.36K
199,738
0.3242%
$772.99K
+206.8%
Carter Todd Alfred
Chief Scientific Officer
—
$367.89K (18) scheduled
−$367.89K
145,718
0.2365%
$563.93K
+302.6%
Turenne Andre
President & CEO
—
$293.26K (3)
−$293.26K
322,375
0.5232%
$1.25M
—
Hesslein Robert W.
Senior VP & General Counsel
—
$258.55K (13)
−$258.55K
102,200
0.1659%
$395.51K
—
PFREUNDSCHUH PETER P.
Chief Financial Officer
—
$122.91K (2)
−$122.91K
175,669
0.2851%
$679.84K
—
GERAGHTY JAMES A
Director
$113.10K (2)
—
+$113.10K
76,588
0.1243%
$296.40K
+8.5%
Ferguson Toby
Chief Medical Officer
—
$105.46K (2)
−$105.46K
183,914
0.2985%
$711.75K
—
Higgins Michael J
Director
—
$93.07K (1)
−$93.07K
31,314
0.0508%
$121.19K
—
Dorval Allison
Chief Financial Officer
—
$91.20K (3)
−$91.20K
109,894
0.1783%
$425.29K
+4,047%
Khwaja Omar
See remarks
—
$85.77K (3)
−$85.77K
120,509
0.1956%
$466.37K
—
Fahey Sandell Jacquelyn
Chief Legal Officer
—
$54.31K (2)
−$54.31K
123,143
0.1998%
$476.56K
—
Jorgensen Nathan D.
Chief Financial Officer
—
$54.24K (2) scheduled
−$54.24K
151,416
0.2457%
$585.98K
—
Ottmer Matthew P.
Chief Operating Officer
—
$49.75K (1)
−$49.75K
26,276
0.0426%
$101.69K
—
Burek Julie
VP, Finance
—
$35.47K (6)
−$35.47K
52,458
0.0851%
$203.01K
+58.9%
PIERCE GLENN
Director
$92.20K (1)
$63.73K (1)
+$28.47K
21,788
0.0354%
$84.32K
—
LEVIN MARK J
Director
—
—
—
6,427,874
10.43%
$24.88M
−42.1%
Shiferman Gregory L.
SVP and General Counsel
—
—
—
50,000
0.0811%
$193.50K
—

Individual transactions

99
Insider
Date
Role
Action
Shares
Price
Amount
Carter Todd Alfred
10 Feb 2026
Chief Scientific Officer
Sell
3,525
$3.85
$13.57K
Sandrock Alfred
10 Feb 2026
President and CEO
Sell
12,192
$3.78
$46.09K
Swartz Robin
10 Feb 2026
COO & CBO
Sell
4,569
$3.85
$17.59K
Ferguson Toby
18 Aug 2025
Chief Medical Officer
Sell
19,000
$3.73
$70.87K
Sandrock Alfred
2 Apr 2025
President and CEO
Sell
10,885
$3.43
$37.34K
Ferguson Toby
2 Apr 2025
Chief Medical Officer
Sell
10,086
$3.43
$34.59K
Swartz Robin
20 Feb 2025
COO & CBO
Sell
3,894
$4.25
$16.55K
Sandrock Alfred
20 Feb 2025
President and CEO
Sell
11,702
$4.24
$49.62K
Carter Todd Alfred
20 Feb 2025
Chief Scientific Officer
Sell
3,305
$4.26
$14.08K
Fahey Sandell Jacquelyn
11 Feb 2025
Chief Legal Officer
Sell
4,358
$4.45
$19.39K
Sandrock Alfred
11 Feb 2025
President & CEO
Sell
16,644
$4.45
$74.07K
Swartz Robin
11 Feb 2025
COO & CBO
Sell
6,950
$4.45
$30.93K
Carter Todd Alfred
11 Feb 2025
Chief Scientific Officer
Sell
5,413
$4.45
$24.09K
Carter Todd Alfred
14 Jan 2025
Chief Scientific Officer
Sell
1,191
$5.13
$6.11K
Swartz Robin
14 Jan 2025
COO & CBO
Sell
3,087
$5.09
$15.71K
Swartz Robin
23 Dec 2024
COO&CBO
Sell
6,500
$5.65
$36.73K
Fahey Sandell Jacquelyn
2 Oct 2024
Chief Legal Officer
Sell
5,999
$5.82
$34.91K
Sandrock Alfred
2 Apr 2024
President and CEO
Sell
12,115
$9.86
$119.45K
Swartz Robin
2 Apr 2024
Chief Operating Officer
Sell
1,357
$9.88
$13.41K
Carter Todd Alfred
21 Feb 2024
Chief Scientific Officer
Sell
3,365
$7.47
$25.14K
PFREUNDSCHUH PETER P.
21 Feb 2024
Chief Financial Officer
Sell
3,764
$7.46
$28.08K
Sandrock Alfred
21 Feb 2024
President and CEO
Sell
13,033
$7.46
$97.23K
Swartz Robin
21 Feb 2024
Chief Operating Officer
Sell
3,966
$7.45
$29.55K
Carter Todd Alfred
20 Feb 2024
Chief Scientific Officer
Sell
602
$7.68
$4.62K
Carter Todd Alfred
17 Jan 2024
Chief Scientific Officer
Sell
1,266
$7.18
$9.09K
Swartz Robin
17 Jan 2024
Chief Operating Officer
Sell
2,543
$7.15
$18.18K
PFREUNDSCHUH PETER P.
3 Oct 2023
Chief Financial Officer
Sell
13,567
$6.99
$94.83K
Swartz Robin
3 Apr 2023
Chief Operating Officer
Sell
1,259
$7.83
$9.86K
Sandrock Alfred
3 Apr 2023
President and CEO
Sell
7,437
$7.83
$58.23K
Hesslein Robert W.
20 Mar 2023
Senior VP & General Counsel
Sell
4,410
$7.76
$34.22K
Swartz Robin
20 Mar 2023
Chief Operating Officer
Sell
3,654
$7.76
$28.36K
Carter Todd Alfred
20 Mar 2023
Chief Scientific Officer
Sell
2,193
$7.76
$17.02K
Swartz Robin
15 Mar 2023
Chief Operating Officer
Sell
15,373
$8.20
$126.06K
Carter Todd Alfred
17 Feb 2023
Chief Scientific Officer
Sell
738
$7.45
$5.50K
Hesslein Robert W.
17 Feb 2023
Senior VP & General Counsel
Sell
3,297
$7.45
$24.56K
Hesslein Robert W.
13 Feb 2023
Senior VP & General Counsel
Sell
2,868
$7.67
$22.00K
Carter Todd Alfred
13 Feb 2023
Chief Scientific Officer
Sell
797
$7.67
$6.11K
Third Rock Ventures III, L.P.
1 Feb 2023
10% owner
Sell
128,642
$9.32
$1.20M
Third Rock Ventures III, L.P.
31 Jan 2023
10% owner
Sell
185,000
$9.25
$1.71M
Third Rock Ventures III, L.P.
30 Jan 2023
10% owner
Sell
75,000
$9.03
$677.25K
Third Rock Ventures III, L.P.
27 Jan 2023
10% owner
Sell
50,000
$9.02
$451.00K
Third Rock Ventures III, L.P.
25 Jan 2023
10% owner
Sell
50,000
$9.22
$461.00K
Third Rock Ventures III, L.P.
24 Jan 2023
10% owner
Sell
100,000
$9.27
$927.00K
Third Rock Ventures III, L.P.
23 Jan 2023
10% owner
Sell
55,000
$9.06
$498.30K
Third Rock Ventures III, L.P.
20 Jan 2023
10% owner
Sell
100,000
$9.15
$915.00K
Swartz Robin
17 Jan 2023
Chief Operating Officer
Sell
792
$10.34
$8.19K
Swartz Robin
17 Jan 2023
Chief Operating Officer
Sell
1,396
$9.57
$13.36K
Carter Todd Alfred
17 Jan 2023
Chief Scientific Officer
Sell
400
$10.34
$4.14K
Carter Todd Alfred
17 Jan 2023
Chief Scientific Officer
Sell
706
$9.57
$6.76K
Hesslein Robert W.
17 Jan 2023
Senior VP & General Counsel
Sell
792
$10.34
$8.19K
Hesslein Robert W.
17 Jan 2023
Senior VP & General Counsel
Sell
1,396
$9.57
$13.36K
EcoR1 Capital, LLC
11 Jan 2023
10% owner
Sell indirect
110,000
$8.50
$934.62K
EcoR1 Capital, LLC
10 Jan 2023
10% owner
Sell indirect
336,400
$8.05
$2.71M
EcoR1 Capital, LLC
9 Jan 2023
10% owner
Sell indirect
456,000
$7.67
$3.50M
Carter Todd Alfred
6 Jan 2023
Chief Scientific Officer
Sell
388
$6.41
$2.49K
Third Rock Ventures III, L.P.
25 Aug 2022
10% owner
Sell
200,000
$6.22
$1.24M
Third Rock Ventures III, L.P.
24 Aug 2022
10% owner
Sell
149,972
$6.09
$913.33K
Third Rock Ventures III, L.P.
16 Aug 2022
10% owner
Sell
128,456
$6.04
$775.87K
Third Rock Ventures III, L.P.
15 Aug 2022
10% owner
Sell
135,808
$6.04
$820.28K
Third Rock Ventures III, L.P.
12 Aug 2022
10% owner
Sell
348,007
$6.12
$2.13M
Higgins Michael J
14 Jul 2022
Director
Sell
13,891
$6.70
$93.07K
PIERCE GLENN
14 Jul 2022
Director
Sell
9,512
$6.70
$63.73K
Hesslein Robert W.
4 Apr 2022
Senior VP & General Counsel
Sell
2,786
$8.25
$22.98K
Swartz Robin
4 Apr 2022
Chief Operating Officer
Sell
1,527
$8.25
$12.60K
Burek Julie
21 Mar 2022
VP, Finance
Sell
31
$8.68
$269.08
Burek Julie
21 Mar 2022
VP, Finance
Sell
2,618
$8.29
$21.70K
Hesslein Robert W.
21 Mar 2022
Senior VP & General Counsel
Sell
58
$8.68
$503.44
Hesslein Robert W.
21 Mar 2022
Senior VP & General Counsel
Sell
4,897
$8.29
$40.60K
Swartz Robin
21 Mar 2022
Chief Operating Officer
Sell
51
$8.68
$442.68
Swartz Robin
21 Mar 2022
Chief Operating Officer
Sell
4,362
$8.29
$36.16K
Burek Julie
17 Feb 2022
VP, Finance
Sell
789
$3.55
$2.80K
Hesslein Robert W.
17 Feb 2022
Senior VP & General Counsel
Sell
4,100
$3.55
$14.56K
Burek Julie
11 Feb 2022
VP, Finance
Sell
361
$3.36
$1.21K
Hesslein Robert W.
11 Feb 2022
Senior VP & General Counsel
Sell
3,252
$3.36
$10.93K
Burek Julie
12 Jan 2022
VP, Finance
Sell
265
$3.06
$810.90
Burek Julie
3 Jan 2022
VP, Finance
Sell
3,063
$2.83
$8.67K
Khwaja Omar
21 May 2021
See remarks
Sell
3,516
$4.03
$14.17K
Hesslein Robert W.
5 Apr 2021
Senior VP & General Counsel
Sell
3,292
$4.95
$16.30K
Khwaja Omar
11 Feb 2021
See remarks
Sell
3,475
$7.55
$26.24K
Hesslein Robert W.
11 Feb 2021
Senior VP & General Counsel
Sell
3,186
$7.55
$24.05K
Dorval Allison
11 Feb 2021
Chief Financial Officer
Sell
3,186
$7.55
$24.05K
Turenne Andre
11 Feb 2021
President & CEO
Sell
7,977
$7.55
$60.23K
Dorval Allison
12 Jan 2021
Chief Financial Officer
Sell
2,942
$8.62
$25.36K
Turenne Andre
12 Jan 2021
President & CEO
Sell
10,443
$8.62
$90.02K
Khwaja Omar
21 May 2020
See remarks
Sell
3,500
$12.96
$45.36K
Hesslein Robert W.
3 Apr 2020
Senior VP & General Counsel
Sell
3,091
$8.51
$26.30K
Turenne Andre
21 Jan 2020
President & CEO
Sell
10,705
$13.36
$143.02K
Ottmer Matthew P.
21 Jan 2020
Chief Operating Officer
Sell
3,724
$13.36
$49.75K
Dorval Allison
21 Jan 2020
Chief Financial Officer
Sell
3,128
$13.36
$41.79K
Ravina Bernard
10 Apr 2018
Chief Medical Officer
Sell
2,451
$18.38
$45.05K
Ravina Bernard
12 Mar 2018
Chief Medical Officer
Sell
2,451
$25.16
$61.67K
Ravina Bernard
12 Feb 2018
Chief Medical Officer
Sell
2,451
$18.24
$44.71K
Ravina Bernard
10 Jan 2018
Chief Medical Officer
Sell
3,630
$16.40
$59.53K
Ravina Bernard
11 Dec 2017
Chief Medical Officer
Sell
5,490
$13.63
$74.83K
Ravina Bernard
10 Nov 2017
Chief Medical Officer
Sell
5,490
$13.26
$72.80K
Ravina Bernard
10 Oct 2017
Chief Medical Officer
Sell
10,980
$20.33
$223.22K
Ravina Bernard
11 Sep 2017
Chief Medical Officer
Sell
10,980
$14.30
$157.01K
Ravina Bernard
5 Sep 2017
Chief Medical Officer
Sell
5,490
$10.00
$54.90K
Ravina Bernard
20 Jul 2017
Chief Medical Officer
Sell
5,490
$10.00
$54.90K
Show all 123 transactions →

What was left out

Form 4 filings counted 260
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 7
Sales at will 99
Transactions with no price 0
Shares from compensation/vesting 13,498,370
Sales filed before the plan box existed 67
History held since 21 Dec 2016